The 340B Drug Pricing Program is a game changer for federally qualified health centers (FQHCs), which have limited flexible funding streams at their disposal and often use their 340B savings for services that are non-reimbursable. The financial impact of these savings cannot be overstated, as they allow FQHCs to stretch their already scarce federal resources as far as possible, enhancing their services and expanding their reach in often overlooked communities.
The 340B Drug Discount Program is in critical danger and must be protected to serve the more than 32 million community health center patients at stake.
See how FQHCs utilize 340B savings in action in this special report from Advocates for Community Health.